CBD and Healthy Sleep: A Null Polysomnography Trial Is Not an Insomnia Treatment Trial
A single 300-mg CBD dose did not significantly change conventional sleep measurements in healthy volunteers. This result neither demonstrates an insomnia treatment nor establishes that CBD has no sleep-related effect under all conditions.
The participants were good sleepers
The randomized, double-blind crossover study compared CBD with placebo using overnight polysomnography. Twenty-six participants contributed the reported study data. Selection favored healthy adults with good baseline sleep quality, rather than people seeking treatment for insomnia.
The preparation was highly purified CBD without THC. A mixed cannabis product, a different dose or repeated use would represent a different exposure.
The measured sleep outcomes were null
The investigators found no statistically significant differences in total sleep time, sleep onset, wakefulness after sleep onset, sleep efficiency or conventional sleep-stage measures. A numerically shorter sleep-onset time with CBD was not a significant result and should not be advertised as demonstrated faster sleep.
Nonsignificance also does not establish formal equivalence. A small experiment may fail to detect subtle changes, and a selected group with satisfactory sleep has limited room for improvement.
What conventional polysomnography misses
The authors note that conventional staging alone may not capture all drug-related EEG changes; spectral analysis could address additional questions. The one-dose design also cannot establish the effects of sustained treatment.
Morning task findings were not a comprehensive driving validation. Without a suitable baseline comparison and a direct driving endpoint, they should not be converted into unrestricted safety advice.
The appropriate clinical inference
The useful finding is that this acute CBD regimen did not disrupt or improve the measured conventional sleep architecture in these healthy adults. Whether a patient with a sleep disorder benefits requires trials in that population, including relevant symptoms, adverse effects and repeated dosing. Preservation of normal sleep in volunteers and treatment of abnormal sleep are separate hypotheses.
For context, see our discussion of THC concentrations and the separate question of impairment.
Primary research
Ila M. P. Linares and colleagues. No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study. Frontiers in Pharmacology (2018). DOI: 10.3389/fphar.2018.00315.
